Nebenwirkungen · Ameluz
Ameluz 78 mg/g gel · Abschnitt 4.8 · PDF-Seite 6
HOS-213732 · Präparat HOS-155182
The incidence of adverse reactions in 624 subjects exposed to photodynamic therapy with Ameluz in pivotal clinical trials is listed below. All these adverse reactions were non serious. The table additionally includes serious adverse reactions reported post-marketing. Frequencies are defined as very common (≥ 1/10), common (≥ 1/100 to < 1/10), uncommon (≥ 1/1 000 to < 1/100), rare (≥ 1/10 000 to < 1/1 000), very rare (< 1/10 000), and not known (frequency cannot be estimated from the available data). Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-06-03T10:20:00Z · SHA-256 4a2d8a709963c8b87ab75f3f376242e6ed45be3b74e9d2d073d1ccaa9ced4211 · Passage ccf7334f05d7901ef5d19cc53b2b9a705e6766e24418923291e6944080364e9c · Zeichen 1378–1984 im Abschnitt